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The DPA*I analyser, a fully automated, discrete, random-access
specijqcprotein analyser has been evaluated. Eight, out ofa current
menu of 17 analytes, were assessed for precision, accuracy and
calibration stability. Within-batch precision was excellent, gener-
ally being between 1% and3%; between-batch precision was also
good (3-6%). Method comparisons showed good agreement; the
best correlations being obtained when the comparison methodology
was also nephelometric.
Calibration stability was a minimum ofone month in each case and
there was no evidence of sample carry-over. The instrument was
easy to use and offered a realistic analysis rate of approximately
100 completed tests per hour.
Automated immunoassay of proteins in serum can be
performed by means ofturbidimetry or nephelometry ].
The DPA*I analyser is a fully automated, discrete
random access specific protein analyser with measure-
ment by rate nephelometry [2]. Although concentrations
are determined by peak rate nephelometry, the system
can kinetically monitor the antigen-antibody reaction of
many tests simultaneously. The system incorporates
sophisticated antigen excess checking procedures and
automatic redilution of samples falling outside the
analytical range of an assay.
The analytical performance of the DPA*I was assessed
for eight different analytes out of a current repertoire of
17. The aspects evaluated included precision, linearity,
calibration stability, relative accuracy, carry-over,
throughput and the validity of the antigen excess
checking procedures.
Materials and methods
The instrument
The Technicon DPA*I (supplied by Technicon UK,
Basingstoke, Hampshire, UK) is a bench-top unit,
comprising an analytical unit with built-in keyboard, a
separate VDU and keyboard, and a printer. A single 13
amp power supply is required. Up to 12 analytes may be
measured at any one time, the antiserum reagent being
supplied, ready-to-use in bar-coded vials, each sufficient
for 100 analyses. A single probe, with level detector,
performs all liquid handling and mixing functions. A
sample is initially diluted in 3"4% polyethylene glycol
(PEG) causing the precipitation of any serum com-
ponents that might interfere in the subsequent measure-
Current address: Department of Clinical Chemistry, Barking Hospital,
Upney Lane, Barking, Essex IGll 9LX, UK.
ment. An aliquot of this diluted sample is mixed with
antiserum and further PEG; the reaction is then moni-
tored every 10 s for a period of 7 min. Measurement is by
nephelometry using a 600 nm pulsed LED light source
and a detection angle of 30. Results are produced at the
rate of three tests/min, irrespective of the number of
samples or tests/sample. A single point calibrator is used,
the standard curve parameters being encoded on the
reagent bar-code label. Samples above and below the
working range of the assay are automatically rediluted
and reanalysed.
There are three methods of checking for antigen excess.
Firstly, the time course of the reaction is automatically
monitored, checking the length of lag phase and time to
peak rate. Secondly, a second aliquot of sample can be
added to the reaction mixture 7 min after completion of
analysis- if no further reaction occurs thesystem is in
antigen excess. Thirdly, ifa rediluted sample is still below
the lower limit ofthe assay, this could be due to a very low
sample concentration; or to the presence of extreme
antigen excess. To distinguish between the two, an
aliquot of control sample is added to the reaction
mixture-if no reaction takes place extreme antigen
excess is indicated.
Analytical methods and reagents
The instrument was used in accordance with the manu-
facturer’s instructions; all calibrators and antiserum
being supplied by Technicon UK. The comparison
methodologies are shown in table 1, as are the sample
volumes used by the DPA*I. Other standards and
controls were obtained from Atlantic Antibodies (Incstar,
Table 1. Method evaluation on the DPA*I.
Analyte
Sample
volume
(1) Comparison method
Immunoglobulin A
ImmunoglobulinG
ImmunoglobulinM
Alpha- 1-antitrypsin
Transferrin
Haptoglobin
ApolipoproteinA
Apolipoprotein B
16 Beckman Array’
10 Beckman ArrayJ"
25 Beckman ArrayS"
15 IL Monarch (Atlantic
Antibodies antiserum) ++
10 IL Multistat (Atlantic
Antibodies antiserum)
12 IL Monarch (Atlantic
Antibodies antiserum) ++
15 IL Multistat (Orion kit)
10 IL Multistat (Immuno Kit)
J" Assayed in the Department of Immunology, The London
Hospital.
++ Assayed in the Department of Clinical Biochemistry, Adden-
brookes Hospital, Cambridge.
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Wokingham, UK), BCL (Lewes, UK), Behring
(Hoescht) (Middlesex, UK), and the Protein Reference
Unit (Sheffield, UK). External quality assessment
samples (EQAS), with results, were supplied by the
Department of Immunology, East Birmingham Hospital
(Birmingham, UK).
Results
Within-batch and between-batch precision data are
shown in tables 2 and 3, respectively. The results for
within-batch precision show excellent performance in all
cases- the majority of the coefficients of variation being
well below 3%. Inter-assay precision was good, generally
Precision
Within-batch precision was assessed by analysing three
pools of serum at high, medium and low concentrations.
The pools were arranged randomly on the 45 place
sample tray and random cups were assayed in duplicate
to give a total of 20 determinations at each level from the
45 samples.
Between-day precision was assayed using a mixture of
frozen pools and commercial quality-control material.
The study covered a single calibration period for alpha-1-
antitrypsin and the apolipoproteins, but more than one
period for the other analytes.
Calibration stability
Each assay was calibrated on day 0, no further calibration
being performed for a period of at least 35 days. The
calibrator and a series ofpools covering a wide concentra-
tion range were assayed as samples during the period to
assess the stability of calibration.
Linearity
To determine the quality of the calibration produced
using a single point calibrator a series of calibrators, in
saline, of a high standard (SPS-02, Protein Reference
Unit, Sheffield, UK) were made. The samples were
assayed two weeks after a single point calibration.
Table 2. Within-batch precisionfor eight analytes on the DPA *I
(N 20for each sample).
Mean CV
Analyte (g/l) SD (%)
ImmunoglobulinA 0"83 0"011 1"3
1"82 0"018 1"0
3-75 0"055 1"5
Immunoglobulin G 4"87 0"055 1"
10"6 0" 10 1"0
28"7 0"59 2"1
ImmunoglobulinM 0"54 0"0087 1"6
1"28 0"044 3"4
"87 0"068 3-6
Alpha- 1-antitrypsin 0"97 0-0130 1"3
1"99 0"034 1"7
3 33 0"040 1"2
Transferrin 0"95 0"0138 "4
2"99 0"059 2"0
5"32 0-158 3"0
Haptoglobin 0-81 0-0116 "4
1"85 0"032 1-7
2"77 0"055 2"0
Apolipoprotein A 0"69 0"0131 "9
1"52 0"048 3"2
"96 0"013 2"
Apolipoprotein B 0-53 0"011 2"
1" 13 0"027 2"4
1"57 0-021 1-4
Table 3. Between-@ precisionfor eight analytes on the DPA*I.
Accuracy
At least 60 patient samples were assayed by the DPA*
and by the comparison methodologies shown in table 1.
In addition, a series of commercial calibrators and
quality materials with quoted values and external quality
assurance samples were analysed by the DPA* 1.
Carry-over
Carry-over was estimated by running four sequences ofa
high pool (x 3) and a low pool (x 3) for immunoglobulin
G.
Throughput
The time taken from commencement of the run to the
final result printout was measured for a variety of
workload patterns.
Antigen excess checking
A total of31 known myeloma samples (15 IgG, 7 IgA and
9 IgM) were used to test the antigen excess software,
consisting of both very high and suppressed immuno-
globulin concentrations.
CV
Analyte Number Mean SD %
ImmunoglobulinA 19 0’845 0"021 2"5
20 2" 15 0"067 3"
20 4"38 0-187 4"3
ImmunoglobulinG 19 4"23 0" 120 2"8
20 10"85 0"576 5"3
20 24-40 1"410 5"8
ImmunoglobulinM 20 0-48 0"023 4"8
19 1" 17 0"049 4"2
20 2"95 0"104 4"8
Alpha- 1-antitrypsin 18 0"74 0"035 4"7
20 1"94 0"067 3"5
19 3"48 0" 104 3"0
Transferrin 19 1"18 0"740 4-7
20 2"25 0"151 6"7
20 5"28 0"299 5"7
Haptoglobin 20 0"59 0"019 3"
20 "25 0"063 5"0
18 2"23 0"131 5"9
Apolipoprotein A 20 0"82 0"051 6"
20 1"19 0"073 6"2
20 1"47 0"082 5"6
Apolipoprotein B 20 0"52 0"027 5"2
20 0"77 0"033 4"0
20 1"28 0"051 6"3
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Figure 1. Calibration stability. Concentration (g/l) of analyte plotted against time (in days).
being between 3% and 5%. This probably could be
improved upon in routine use as the data included a short
time of poor precision, which was probably caused by a
slightly blocked probe.
Calibration stability
The measured concentrations of various pools of the
different analytes over a minimum of 35 days are shown
in figure 1. In all cases, calibration appeared stable for
this period of time, i.e. greater than the 2-week period
claimed by the suppliers.
Linearity
All methods were linear over the range of the assay, as
shown in figure 2, confirming the suitability of the
curve-fit parameters encoded on the reagent bar code.
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Figure 2. Linearity. Found concentration (g/1) plotted against calculated concentration (g/l). Working range ofprimary dilution indicated
by arrows.
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Figure 3. Comparison studies. Concentration (g/l) measured by DPA*I plotted against that measured by comparison methodology.
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Accuracy
The method comparison studies are shown in figure 3.
Good correlation coefficients (table 4) were obtained for
all analytes, apart from apolipoprotein A1; particularly
good figures were obtained when the comparison method
also used a rate nephelometric approach. Slopes signifi-
cantly different from unity were seen for alpha-1-
antitrypsin, haptoglobin and apolipoprotein B, all due to
the use of different calibration materials for the compari-
son method. The concentrations found for a series of
commercial calibrators and controls are shown in table 5.
Table 4. Linear regression statisticsfor DPA*I (y-axis) against
various comparison methods (x-axis).
Correlation
Test N Slope Y-intercept coefficient
ImmunoglobulinA 65 1"061 -0-038 0"996
ImmunoglobulinG 60 1" 138 1-391 0-990
ImmunoglobulinM 64 1"036 -0-145 0"990
Alpha- 1-antitrypsin 70 1-534 -0"28 0"94
Transferrin 60 1" 148 +0-652 0-90
Haptoglobin 70 1-395 -0" 196 0"95
Apolipoprotein A1 64 1"05 +0" 10 0"78
Apolipoprotein B 64 0-79 +0"06 0"93
The immunoglobulin values obtained for myeloma
samples (figure 4[a]) were lower than for the comparison
method (slope 0"85), but the concentration measured
showed slightly better agreement with results produced
by serum electrophoresis (agarose) and densitometric
scanning (figure 4[b]), whereas agreement between the
scanning and comparison method was not as good (data
not shown).
Carry-over
The sequence H1HH3L1L2L3 was repeated four times
for two immunoglobulin G pools and gave the following
data:
L1 3-796 g/1
L3 3"800 g/1
H 28"0 g/1
SD 0"051
SD 0-034
L1 and L3 are not significantly different, indicating that
carry-over was negligible.
Throughput
The throughput of the machine is dependent on the
number of tests, not samples, and also on whether
redilutions and automated antigen excess checking are
undertaken. Figure 5 shows the time taken for a variety of
workload patterns; thus, 60 tests can be analysed in 30
min if there are no redilutions etc. In the extreme cases
using only known myelomas and antigen excess checking
on all samples and many redilutions being performed,
100 tests can take approximately 140 min. Overall, a
realistic analysis rate appears to be of the order of 100
tests/h.
Table 5. Comparison ofstated concentration and concentration as
analysed by DPA *1for various calibrators and quality assurance
materials.
Analyte Material
Stated Found
valueJ" value
(g/l) (g/l)
ImmunoglobulinA Atlantic Antibodies 4"86 4"36
CA
Behring N-Protein 2"38 2" 15
Atlantic Antibodies 0"83 0-85
lowQC
SPS-01 ++ 2" 18 2"02
SPS-02 4-83 4-44
EQAS 61 1"69 1-51
EQAS 62 1"77 1"60
EQAS 63 0"38 0"32
EQAS 64 42"7 53"8
ImmunoglobulinG AtAB CA 26"32 24"43
Behring N-Protein 11-4 10"85
AtAB lowQC 4"32 4"23
SPS-01 11"32 11"27
SPS-02 25"33 23"71
EQAS 61 9"65 9"53
EQAS 62 10"41 10"20
EQAS 63 2"21 1"92
EQAS 64 3"63 3-24
ImmunoglobulinM AtAB CA 2"69 2"95
Behring N-Protein 1" 10 0-79
AtAB lowQC 0-41 0"48
SPS-01 1"21 1"16
SPS-02 2"82 2"47
EQAS 61 1"37 1"76
EQAS 62 1-43 1"33
EQAS 63 0"43 0"34
EQAS 64 0"28 0" 16
Alpha-l-antitrypsin AtAB CA 3 3"72 3-48
Behring N-Protein 2" 19 "95
AtAB LowQC 0"77 0"64
SPS-01 1"66 1"99
EQAS 61 1"44 1-49
EQAS 62 1"47 1"63
EQAS 63 1"60 1"76
EQAS 64 1" 14 1" 13
Transferrin AtAB CA 3 5"51 5"29
Behring N-Protein 3"00 3" 11
At AB LowQC 1-26 1" 18
SPS-01 2"19 3"10
SPS-02 4"87 5"9
Haptoglobin AtAB CA 3 2" 11 2"23
Behring N-Protein 1-69 1"25
AtAB LowQC 0"54 0-59
Apolipoprotein A1 Immuno Normal QC 1"27 0"82
Behring Precision L 1"42 1-78
Apolipoprotein B Immuno Normal QC 1-00 0"52
Behring Precision L 0-79 0"74
"
(Or all lab mean for EQAS samples.)
++ See [3] for details of SPS-01.
Antigen excess checking
Table 6 indicates the range of values obtained for the 31
myeloma samples and also whether any antigen excess
flags were produced. The figures for IgG indicate the
wide range of the assay, with antigen excess not being
encountered. Immunoglobulin A produced one failure of
the curve fit software in that, for one sample with a low
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level of IgA, extreme antigen excess was indicated if the
’control add-back’ option was used; if only the second
sample addition was used the result was correctly
recorded as low. In the case of IgM, one myeloma was
missed by all three methods of antigen excess checking.
instrument. A level sensor for the PEG diluent would be
needed to consolidate the simplicity of use.
Within-day precision was excellent and between-day
precision was good and could probably be improved upon
in routine use.
Discussion
The software, the bar-coded calibrators and the ready-to-
use reagents all contributed to the ease of use of the
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Figure 4. Comparison studies for samples containing a para-
protein. (a) DPA*I versus comparison method; (b) DPA*I
versus densitometric scanning, IgG, Q) IgM, A IgA.
Calibration appeared stable throughout a 35 day period
in all cases, indicating that monthly calibration should be
sufficient. All methods were linear over the assay range,
indicating the validity of the curve parameters and single
point calibration.
Comparison with other methods was generally good,
although the correlation coefficient for apolipoprotein A1
was less good. The significant slopes obtained for some
assays is partly due to the difference in assigned values of
the relative calibrants, though for alpha-l-antitrypsin
and haptoglobin the slope ofcorrelation was greater than
the relative concentrations of the Technicon standard in
the two measurement systems.
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Figure 5. Evaluation of throughput.
Table 6. Results of antigen excess checking software on 31 samplesfrom known myeloma patients.
IgA IgG IgM
Number ofsamples
Concentration range
Myeloma
Overall
Number offlags with antigen
excess software
Number offlags with extreme
antigen excess software
7 15 9
5.1-32-1
0.06-32"
(33.1 g/l)
3 correctly
flagged low
extremely
Ag XS but
result low
13"8-49"4
2" 14-49-4
None
None
6.7-20.8
0.08-20.8
Ag Excess
curve fit failure
missed
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The difference in assigned calibration values is reflected
in the concentrations measured for different calibrators
for the analytes. The DPA*I is calibrated against the
American College of Pathologists’ reference preparation,
although the software allows for the reassignment of the
stated values for the calibrator to be adjusted so as to give
results calibrated against a different reference prepara-
tion.
The correlation data for transferrin showed a significant
intercept on the y-axis, although the straight line of the
dilution curve indicates that the DPA*I is probably
correct. There was no evidence of carry-over within the
system, the washing procedure being satisfactory.
The antigen excess checking procedures are generally
satisfactory, although two errors occurred. It is suggested
that it is still advisable to run a total protein or serum
protein electrophoresis if undertaking immunoglobulin
assays for the first time on a patient this would indicate
any samples likely to produce antigen excess in the assay
system. For known paraproteins the analyser will give
consistent results and such a procedure would be
unnecessary [4].
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